Ampelis Health logo

 435-776-5909

Transcranial magnetic stimulation (TMS) has gained a lot of attention recently for its success at treating depression, with recent studies backing up its efficacy as a depression treatment. New TMS research is being published constantly. We review recent TMS studies, their findings, and their implications for those struggling with depression. Read on to learn more about the latest successful TMS results and research.

In this article:

What Is TMS?

TMS is an innovative and non-invasive therapeutic approach that harnesses magnetic fields to stimulate brain nerve cells. This cutting-edge treatment precisely targets the regions of the brain that are responsible for mood control, offering a promising solution for individuals experiencing mood disorders such as depression.

By applying magnetic pulses to these specific areas, TMS aims to modulate neural activity and restore a healthier balance, potentially leading to improved mood and overall well-being. Unlike medication or electroconvulsive therapy (ECT), TMS is a non-invasive treatment. TMS does not involve taking pharmaceutical drugs or use of anesthesia, making it a safer and more comfortable option for many patients. With its potential to revolutionize the field of mental health, TMS offers a promising avenue for those seeking effective and non-invasive treatment options.

One key aspect of TMS therapy is its ability to be tailored to each individual’s needs. By taking into account factors such as the patient’s specific symptoms, medical history, and brain imaging data, providers can customize the treatment protocol to optimize its effectiveness. Ensuring the most targeted and beneficial treatment for patients, this personalized approach increases the likelihood of positive long-term results.

What Does TMS Research Say About Response and Remission Rates?

TMS has been extensively researched now for several decades. Research results have been overwhelmingly positive, with multiple studies finding high response and remission rates for TMS treatment.

A 2021 technology assessment by Ontario Health undertook an extensive review of published TMS research studies to determine whether to provide TMS treatment within its health system. The study found consistent support for TMS delivering higher response and remission rates than other treatment methods in patients with treatment-resistant depression. Additionally, the study found that patients who had received TMS treatment had strong positive experiences and attitudes toward TMS treatment. (Source)

An extensive post-marketing data analysis, conducted in 2023, saw impressively successful TMS results. The study showed an 81.6% response rate and a remarkable 65.3% remission rate. It is important to note that the term ‘response’ was defined as a significant 50% reduction in symptoms based on a standardized depression screening tool, while ‘remission’ indicated the point at which patients no longer met the criteria for a depression diagnosis.

Is TMS Effective for Everyone?

Depression and anxiety are complex diseases with multiple contributing factors. Because ofPerson living free of depression after TMS treatment the complexity and individuality of depression, response and remission rates can differ from person to person. With any treatment study there will be natural variations in results due to different study methodologies, patient populations, severity levels of depression, and other contributing factors.

For instance, a 2019 study featured in the National Library of Medicine found that while TMS has successful results in treating depression, individual outcomes may vary based on factors such as the severity of the depression, the specific protocols utilized, and the patient’s overall health and lifestyle. However, the same is true for all depression treatments, including therapy and antidepressants.

The Future of TMS

TMS has been so successful at treating depression that it is being tested for use in treating other conditions linked to the brain. TMS has already received regulatory clearance in other countries to treat brain-related conditions such as cognitive decline, Parkinson’s, schizophrenia, and bipolar disorder. In the US, trials are underway to obtain FDA approval to use TMS in treating these conditions as well.

Due to its strong record of safety and efficacy at treating depression, it is likely that TMS treatment will soon be available as a standard treatment for many other mental and physical health conditions.

Choosing the Right TMS Provider

Where you receive TMS makes a difference. Not every TMS provider has the same skill level or care philosophy. Choosing the right provider can significantly impact the success of your treatment. At Ampelis Health, we are committed to delivering the highest standard of care. Our TMS treatment is combined with additional study material, developed by leading experts, that drives higher patient outcomes and establishes patterns for long-term success.

Our team is dedicated to providing the highest level of care to ensure the well-being and recovery of each individual we serve. We strive to create an intimate, supportive environment where patients can achieve the best possible result. Contact us today to learn more about how TMS can help you conquer depression.

img-4
Welcome to Ampelis! Please fill out the form below and we will be in touch shortly.